Search Results

New insights into the treatment of obesity

• Authors : Blüher, Matthias; Aras, Mohini; Aronne, Louis J. ...

Subjects: Gip; GLP-1 analogue; Antiobesity drug

Record details

2023 Update ; Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

• Authors : Bertoluci, Marcello Casaccia; Silva Júnior, Wellington S; Valente, Fernando ...

Subjects: ASCVD; Atherosclerotic disease; Cardiovascular risk

Record details

Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results ; can definition of established cardiovascular disease be the missing link?

• Authors : Melo, Miguel; Gavina, Cristina; Silva-Nunes, José ...

Subjects: Antidiabetic drug; Cardiovascular disease; Cardiovascular outcome trials

Record details

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

• Authors : Sanchez-Garrido, Miguel A.; Tena-Sempere, Manuel;

Subjects: PCOS; Androgen excess; Insulin resistance

Record details

Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D).

• Authors : Schernthaner, G.; Khunti, K.; Lotan, C.

Subjects: CVOT; DPP-4 inhibitors; GLP-1 agonists

• Source: Therapeutics and clinical risk management, vol. 13, pp. 1569-1576

Record details

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

• Authors : Miñambres, Inka; Pérez, Antonio

Subjects: Type 2 diabetes mellitus; Glycemic control; Postprandial glycemia

Record details

The cardiovascular safety of incretin-based therapies: a review of the evidence

• Authors : Petrie, John R

Subjects: Type 2 diabetes mellitus; Cardiovascular safety; Incretin

Record details

Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment

• Authors : Sharma, Alok; Paliwal, Geetanjali; Upadhyay, Nisha

Subjects: Type 2 diabetes; DPP-4; GLP-1

Record details

Can GLP-1 be a target for reward system related disorders? a qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol

• Authors : Eser, Hale Yapıcı (ORCID 0000-0003-0318-2770 & YÖK ID 134359); Eren Yazıcıoğlu, Candan Yasemin; Yiğit, Arya

Subjects: Medicine; Behavioral sciences; Neurosciences and neurology

• Source: Frontiers in Behavioral Neuroscience

Record details

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus

• Authors : Nisal, Kaustubh; Kela, Ram; Khunti, Kamlesh

Subjects: GLP-1 analogues; GLP-1 agonists; DPP-4 inhibitors

Record details